Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Endonovo Therapeutics shares last traded at $0.00, with a volume of 4,043,300 shares trading hands.
Endonovo Therapeutics Stock Performance
Endonovo Therapeutics Company Profile
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Further Reading
- Five stocks we like better than Endonovo Therapeutics
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Profitably Trade Stocks at 52-Week Highs
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.